InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Altarac David, Directeur Médical. Director active across 1 company, notably Entasis Therapeutics Holdings Inc.. Cumulatively, 6 disclosures have been logged. History available since 19 October 2021. The latest transaction was filed on 18 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
125,000 shares0Common StockSEC:0001104659-22-005409
125,000 shares0Common StockSEC:0001104659-22-005409:0
3,669 shares@ US$2.9450.0% of flowCommon StockSEC:0001104659-21-133630:0
3,669 shares@ US$2.94100.0% of flowCommon StockSEC:0001104659-21-133630
25,000 shares0Common StockSEC:0001104659-21-128056
25,000 shares0Common StockSEC:0001104659-21-128056:0
6 of 6 declarations
About Altarac David
David Altarac is the Chief Medical Officer of Entasis Therapeutics Holdings Inc. He oversees the clinical and medical aspects of the company's research and development projects. His medical expertise is essential to ensure the quality and efficacy of the treatments developed.
